ONTOLOGY REPORT - ANNOTATIONS
| Term: | ethanol |
|
| Accession: | CHEBI:16236
|
browse the term
|
| Definition: | A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group. |
| Synonyms: | related_synonym: | 1-hydroxyethane; Aethanol; Aethylalkohol; Alkohol; C2H5OH; C2H6O; CCO; Dehydrated ethanol; EtOH; Ethyl alcohol; InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3; InChIKey=LFQSCWFLJHTTHZ-UHFFFAOYSA-N; Methylcarbinol; [CH2Me(OH)]; [OEtH]; alcohol; alcohol etilico; alcool ethylique; etanol; hydroxyethane; spiritus vini |
| | alt_id: | CHEBI:14222; CHEBI:23978; CHEBI:30878; CHEBI:30880; CHEBI:42377; CHEBI:44594; CHEBI:4879 |
| | xref_casrn: | 64-17-5 |
| | xref: | Beilstein:1718733 "Beilstein Registry Number"; ChEBI:c0038 "UM-BBD compID"; ChEMBL:113618 "ChEMBL COMPOUND"; ChemIDplus:64-17-5 "CAS Registry Number"; CiteXplore:11046114 "PubMed citation"; CiteXplore:11090978 "PubMed citation"; CiteXplore:11198720 "PubMed citation"; CiteXplore:11200745 "PubMed citation"; CiteXplore:11262320 "PubMed citation"; CiteXplore:11303910 "PubMed citation"; CiteXplore:11333032 "PubMed citation"; CiteXplore:11505026 "PubMed citation"; CiteXplore:11590970 "PubMed citation"; CiteXplore:11728426 "PubMed citation"; CiteXplore:11750186 "PubMed citation"; CiteXplore:11754521 "PubMed citation"; CiteXplore:11810019 "PubMed citation"; CiteXplore:11826039 "PubMed citation"; CiteXplore:11981228 "PubMed citation"; CiteXplore:12824058 "PubMed citation"; CiteXplore:12829422 "PubMed citation"; CiteXplore:12888778 "PubMed citation"; CiteXplore:12946583 "PubMed citation"; CiteXplore:14674846 "PubMed citation"; CiteXplore:15019421 "PubMed citation"; CiteXplore:15239123 "PubMed citation"; CiteXplore:15285839 "PubMed citation"; CiteXplore:15464411 "PubMed citation"; CiteXplore:15465973 "PubMed citation"; CiteXplore:15749123 "PubMed citation"; CiteXplore:15900217 "PubMed citation"; CiteXplore:15902919 "PubMed citation"; CiteXplore:16084479 "PubMed citation"; CiteXplore:16133132 "PubMed citation"; CiteXplore:16352430 "PubMed citation"; CiteXplore:16390872 "PubMed citation"; CiteXplore:16737463 "PubMed citation"; CiteXplore:16891664 "PubMed citation"; CiteXplore:16934862 "PubMed citation"; CiteXplore:17043811 "PubMed citation"; CiteXplore:17190852 "PubMed citation"; CiteXplore:17663926 "PubMed citation"; CiteXplore:17687877 "PubMed citation"; CiteXplore:18095657 "PubMed citation"; CiteXplore:18249266 "PubMed citation"; CiteXplore:18320157 "PubMed citation"; CiteXplore:18347649 "PubMed citation"; CiteXplore:18408978 "PubMed citation"; CiteXplore:18411066 "PubMed citation"; CiteXplore:18456322 "PubMed citation"; CiteXplore:18513832 "PubMed citation"; CiteXplore:18922656 "PubMed citation"; CiteXplore:18925476 "PubMed citation"; CiteXplore:19280886 "PubMed citation"; CiteXplore:19359288 "PubMed citation"; CiteXplore:19384566 "PubMed citation"; CiteXplore:19458312 "PubMed citation"; CiteXplore:19851413 "PubMed citation"; CiteXplore:19901811 "PubMed citation"; CiteXplore:21600756 "PubMed citation"; CiteXplore:21762181 "PubMed citation"; CiteXplore:21881875 "PubMed citation"; CiteXplore:21967628 "PubMed citation"; CiteXplore:22019193 "PubMed citation"; CiteXplore:22222864 "PubMed citation"; CiteXplore:22261437 "PubMed citation"; CiteXplore:22286266 "PubMed citation"; CiteXplore:22306018 "PubMed citation"; CiteXplore:22331491 "PubMed citation"; CiteXplore:22336593 "PubMed citation"; DrugBank:DB00898 "DrugBank"; Gmelin:787 "Gmelin Registry Number"; HMDB:HMDB00108 "HMDB"; KEGG COMPOUND:64-17-5 "CAS Registry Number"; KEGG COMPOUND:C00469 "KEGG COMPOUND"; KEGG DRUG:D00068 "KEGG DRUG" |
| | xref_mesh: | MESH:D000431 |
| | xref: | MetaCyc:ETOH "MetaCyc"; MolBase:858 "MolBase"; MolBase:859 "MolBase"; NIST Chemistry WebBook:64-17-5 "CAS Registry Number"; PDBeChem:EOH "PDBeChem"; Reaxys:1718733 "Reaxys Registry Number"; Wikipedia:Ethanol "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:52092 |
|
|
ethanol
|
| G |
2610528J11Rik |
RIKEN cDNA 2610528J11 gene |
|
multiple interactions |
ISO |
4 |
118,199,880 |
118,202,822 |
RGD:6480464 |
CTD |
| G |
Abat |
4-aminobutyrate aminotransferase |
|
multiple interactions |
ISO |
16 |
8,513,522 |
8,621,661 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
|
multiple interactions |
EXP |
11 |
84,008,940 |
84,215,153 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
|
increases expression |
EXP |
11 |
84,008,940 |
84,215,153 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-Coenzyme A dehydrogenase, long-chain |
|
multiple interactions |
EXP |
1 |
66,877,427 |
66,909,841 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
|
increases expression |
EXP |
3 |
153,585,323 |
153,607,396 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
decreases expression |
ISO |
7 |
86,198,369 |
86,259,985 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
ISO |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
multiple interactions |
ISO |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
increases expression |
ISO |
12 |
85,328,811 |
85,334,827 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
multiple interactions |
ISO |
12 |
85,328,811 |
85,334,827 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
multiple interactions |
ISO |
12 |
85,393,101 |
85,400,515 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
8 |
47,556,396 |
47,621,404 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
ISO |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
ISO |
6 |
83,462,903 |
83,486,245 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
increases expression |
ISO |
6 |
83,462,903 |
83,486,245 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 |
|
decreases expression |
ISO |
1 |
127,289,483 |
127,332,067 |
RGD:6480464 |
CTD |
| G |
Adam17 |
a disintegrin and metallopeptidase domain 17 |
|
decreases expression |
ISO |
12 |
21,329,370 |
21,379,452 |
RGD:6480464 |
CTD |
| G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
|
decreases expression |
ISO |
8 |
114,490,808 |
114,516,202 |
RGD:6480464 |
CTD |
| G |
Adcy10 |
adenylate cyclase 10 |
|
decreases expression |
ISO |
1 |
167,415,314 |
167,506,904 |
RGD:6480464 |
CTD |
| G |
Adcy10 |
adenylate cyclase 10 |
|
multiple interactions |
ISO |
1 |
167,415,314 |
167,506,904 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 |
|
increases expression |
ISO |
13 |
68,758,920 |
69,138,419 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
increases expression |
ISO |
12 |
4,133,397 |
4,213,524 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
decreases expression |
ISO |
16 |
35,155,722 |
35,304,635 |
RGD:6480464 |
CTD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
decreases expression |
ISO |
15 |
98,420,409 |
98,438,064 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 |
|
increases expression |
ISO |
15 |
64,530,597 |
64,753,858 |
RGD:6480464 |
CTD |
| G |
Adcy9 |
adenylate cyclase 9 |
|
increases expression |
ISO |
16 |
4,287,545 |
4,419,587 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
ISO |
17 |
93,598,762 |
93,604,831 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
decreases expression |
ISO |
17 |
93,598,762 |
93,604,831 |
RGD:6480464 |
CTD |
| G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
decreases expression |
ISO |
6 |
55,401,974 |
55,451,449 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
EXP |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases metabolic processing |
EXP |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
EXP |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
EXP |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases expression |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases metabolic processing |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
multiple interactions |
EXP |
3 |
138,078,461 |
138,093,856 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
decreases expression |
EXP |
3 |
138,078,461 |
138,093,856 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
increases oxidation |
ISO |
3 |
138,078,461 |
138,093,856 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
affects oxidation |
ISO |
3 |
138,078,461 |
138,093,856 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
EXP |
3 |
138,106,128 |
138,118,463 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
increases oxidation |
ISO |
3 |
138,106,128 |
138,118,463 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
ISO |
3 |
138,106,128 |
138,118,463 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenergic receptor, alpha 1a |
|
multiple interactions |
ISO |
14 |
67,254,095 |
67,352,166 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
affects expression |
ISO |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Aes |
amino-terminal enhancer of split |
|
multiple interactions |
ISO |
10 |
81,022,305 |
81,029,109 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
affects expression |
ISO |
4 |
155,539,399 |
155,559,244 |
RGD:6480464 |
CTD |
| G |
Agtpbp1 |
ATP/GTP binding protein 1 |
|
multiple interactions |
ISO |
13 |
59,550,896 |
59,658,680 |
RGD:6480464 |
CTD |
| G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
|
multiple interactions |
ISO |
15 |
10,288,334 |
10,339,493 |
RGD:6480464 |
CTD |
| G |
Ak3 |
adenylate kinase 3 |
|
decreases expression |
ISO |
19 |
29,095,322 |
29,122,392 |
RGD:6480464 |
CTD |
| G |
Akr1b3 |
aldo-keto reductase family 1, member B3 (aldose reductase) |
|
decreases expression |
ISO |
6 |
34,253,930 |
34,267,489 |
RGD:6480464 |
CTD |
| G |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
|
multiple interactions |
ISO |
13 |
4,267,418 |
4,278,645 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinic acid synthase 1 |
|
multiple interactions |
ISO |
9 |
106,135,786 |
106,150,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
|
increases expression |
ISO |
19 |
20,676,472 |
20,717,952 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
decreases activity |
ISO |
6 |
90,500,842 |
90,549,165 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
decreases expression |
ISO |
6 |
90,500,842 |
90,549,165 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
multiple interactions |
ISO |
6 |
90,500,842 |
90,549,165 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
affects response to substance |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
affects response to substance |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
increases metabolic processing |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
increases response to substance |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
affects response to substance |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase family 3, subfamily A1 |
|
multiple interactions |
EXP |
11 |
61,022,244 |
61,031,920 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase family 3, subfamily A1 |
|
increases activity |
EXP |
11 |
61,022,244 |
61,031,920 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
EXP |
7 |
133,938,748 |
133,943,961 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
ISO |
7 |
133,938,748 |
133,943,961 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
EXP |
7 |
117,916,118 |
117,955,909 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
EXP |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
5 |
97,222,404 |
97,274,987 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
EXP |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
ISO |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
increases expression |
ISO |
9 |
46,041,134 |
46,043,380 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
ISO |
12 |
70,473,137 |
70,476,967 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
decreases expression |
ISO |
12 |
53,617,064 |
53,668,839 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
decreases expression |
ISO |
3 |
95,238,312 |
95,301,162 |
RGD:6480464 |
CTD |
| G |
Arrb1 |
arrestin, beta 1 |
|
decreases expression |
ISO |
7 |
106,683,996 |
106,755,281 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
affects expression |
ISO |
11 |
70,246,155 |
70,254,176 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
increases expression |
ISO |
11 |
70,246,155 |
70,254,176 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
ISO |
13 |
81,022,683 |
81,035,303 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
|
multiple interactions |
ISO |
8 |
42,425,997 |
42,460,051 |
RGD:6480464 |
CTD |
| G |
Ascl2 |
achaete-scute complex homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
7 |
150,152,727 |
150,155,169 |
RGD:6480464 |
CTD |
| G |
Asgr1 |
asialoglycoprotein receptor 1 |
|
increases expression |
ISO |
11 |
69,867,871 |
69,871,396 |
RGD:6480464 |
CTD |
| G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
increases expression |
ISO |
11 |
69,906,146 |
69,919,689 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
decreases expression |
ISO |
16 |
45,158,942 |
45,188,651 |
RGD:6480464 |
CTD |
| G |
Atn1 |
atrophin 1 |
|
multiple interactions |
ISO |
6 |
124,692,562 |
124,706,505 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
affects expression |
ISO |
9 |
96,233,092 |
96,264,718 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
affects expression |
ISO |
10 |
98,377,786 |
98,488,777 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) |
|
increases expression |
ISO |
11 |
95,934,107 |
95,937,008 |
RGD:6480464 |
CTD |
| G |
Atp6ap1 |
ATPase, H+ transporting, lysosomal accessory protein 1 |
|
decreases expression |
ISO |
X |
71,542,436 |
71,550,060 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc |
|
increases expression |
ISO |
5 |
138,422,749 |
138,431,461 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
multiple interactions |
ISO |
17 |
27,156,757 |
27,165,571 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
affects response to substance |
EXP |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
affects localization |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
affects localization |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
affects localization |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
decreases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
11 |
101,149,581 |
101,163,581 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases degradation |
ISO |
11 |
101,149,581 |
101,163,581 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
decreases expression |
ISO |
11 |
101,149,581 |
101,163,581 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine methyltransferase |
|
increases expression |
ISO |
13 |
94,386,846 |
94,407,713 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer |
|
multiple interactions |
ISO |
15 |
83,357,292 |
83,375,065 |
RGD:6480464 |
CTD |
| G |
Bpifa1 |
BPI fold containing family A, member 1 |
|
decreases expression |
EXP |
2 |
153,968,616 |
153,974,953 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin |
|
decreases expression |
ISO |
10 |
79,167,103 |
79,174,724 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
decreases expression |
ISO |
5 |
44,210,132 |
44,234,707 |
RGD:6480464 |
CTD |
| G |
Btg2 |
B cell translocation gene 2, anti-proliferative |
|
decreases expression |
ISO |
1 |
135,971,442 |
135,975,732 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
|
decreases expression |
ISO |
4 |
136,436,060 |
136,442,092 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
increases expression |
ISO |
4 |
104,438,922 |
104,477,153 |
RGD:6480464 |
CTD |
| G |
C920025E04Rik |
RIKEN cDNA C920025E04 gene |
|
multiple interactions |
ISO |
17 |
36,246,172 |
36,248,615 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
5 |
15,440,509 |
15,880,329 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
47,338,435 |
47,661,468 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
|
multiple interactions |
EXP |
7 |
121,774,992 |
121,779,871 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
|
affects response to substance |
ISO |
7 |
121,774,992 |
121,779,871 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
ISO |
12 |
101,437,751 |
101,448,016 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
decreases expression |
ISO |
17 |
87,832,741 |
87,846,275 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
ISO |
7 |
17,481,248 |
17,501,262 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
multiple interactions |
ISO |
7 |
17,481,248 |
17,501,262 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
decreases expression |
ISO |
18 |
61,085,286 |
61,147,806 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
|
decreases expression |
ISO |
11 |
5,869,645 |
5,965,751 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II, delta |
|
increases expression |
ISO |
3 |
126,299,891 |
126,547,972 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
decreases expression |
ISO |
14 |
21,554,097 |
21,613,310 |
RGD:6480464 |
CTD |
| G |
Cand1 |
cullin associated and neddylation disassociated 1 |
|
multiple interactions |
ISO |
10 |
118,635,868 |
118,677,111 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
affects expression |
ISO |
11 |
50,107,459 |
50,139,175 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
affects expression |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Car2 |
carbonic anhydrase 2 |
|
decreases expression |
EXP |
3 |
14,886,426 |
14,900,770 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
increases expression |
ISO |
3 |
14,863,538 |
14,872,381 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
multiple interactions |
ISO |
11 |
84,771,256 |
84,779,556 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase 1 |
|
increases expression |
ISO |
2 |
30,040,651 |
30,061,219 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
affects secretion |
EXP |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
affects secretion |
EXP |
11 |
83,476,086 |
83,478,185 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
multiple interactions |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
multiple interactions |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd48 |
CD48 antigen |
|
multiple interactions |
ISO |
1 |
173,612,186 |
173,635,388 |
RGD:6480464 |
CTD |
| G |
Cdc37l1 |
cell division cycle 37-like 1 |
|
decreases expression |
ISO |
19 |
29,064,984 |
29,092,059 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
decreases expression |
ISO |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
multiple interactions |
ISO |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdh17 |
cadherin 17 |
|
decreases expression |
ISO |
4 |
11,685,304 |
11,745,052 |
RGD:6480464 |
CTD |
| G |
Cdk20 |
cyclin-dependent kinase 20 |
|
affects response to substance |
ISO |
13 |
64,533,861 |
64,541,029 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
affects expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases activity |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Ces1g |
carboxylesterase 1G |
|
multiple interactions |
ISO |
8 |
95,826,268 |
95,861,108 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
ISO |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Chat |
choline acetyltransferase |
|
multiple interactions |
ISO |
14 |
33,221,389 |
33,279,095 |
RGD:6480464 |
CTD |
| G |
Chat |
choline acetyltransferase |
|
decreases expression |
ISO |
14 |
33,221,389 |
33,279,095 |
RGD:6480464 |
CTD |
| G |
Chdh |
choline dehydrogenase |
|
increases expression |
ISO |
14 |
30,822,186 |
30,853,652 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
|
decreases expression |
ISO |
7 |
70,243,578 |
70,357,412 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
ISO |
10 |
17,443,034 |
17,445,480 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member f |
|
multiple interactions |
ISO |
6 |
83,594,536 |
83,606,110 |
RGD:6480464 |
CTD |
| G |
Clk3 |
CDC-like kinase 3 |
|
decreases expression |
ISO |
9 |
57,598,518 |
57,613,667 |
RGD:6480464 |
CTD |
| G |
Clns1a |
chloride channel, nucleotide-sensitive, 1A |
|
increases expression |
ISO |
7 |
104,845,201 |
104,867,389 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects expression |
ISO |
4 |
34,011,607 |
34,035,806 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects response to substance |
EXP |
4 |
34,011,607 |
34,035,806 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
decreases expression |
ISO |
4 |
34,011,607 |
34,035,806 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
6 |
4,455,697 |
4,491,543 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
6 |
4,455,697 |
4,491,543 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
decreases expression |
ISO |
15 |
97,806,033 |
97,835,155 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression |
ISO |
7 |
135,348,949 |
135,349,880 |
RGD:6480464 |
CTD |
| G |
Cox6c |
cytochrome c oxidase subunit VIc |
|
increases expression |
ISO |
15 |
35,861,731 |
35,868,001 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1, pancreatic |
|
multiple interactions |
ISO |
6 |
30,589,221 |
30,595,361 |
RGD:6480464 |
CTD |
| G |
Cpa2 |
carboxypeptidase A2, pancreatic |
|
multiple interactions |
ISO |
6 |
30,491,642 |
30,514,473 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
increases expression |
ISO |
11 |
76,590,710 |
76,660,510 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
decreases expression |
EXP |
19 |
3,323,301 |
3,385,733 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
decreases expression |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
decreases expression |
ISO |
4 |
43,575,506 |
43,579,932 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
decreases expression |
ISO |
16 |
4,084,048 |
4,213,404 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
16 |
4,084,048 |
4,213,404 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
ISO |
18 |
3,266,352 |
3,337,587 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
affects expression |
ISO |
3 |
19,593,401 |
19,595,396 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
ISO |
3 |
19,593,401 |
19,595,396 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases expression |
ISO |
3 |
19,593,401 |
19,595,396 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Crybb3 |
crystallin, beta B3 |
|
decreases expression |
ISO |
5 |
113,504,859 |
113,510,604 |
RGD:6480464 |
CTD |
| G |
Crybb3 |
crystallin, beta B3 |
|
decreases expression |
EXP |
5 |
113,504,859 |
113,510,604 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
decreases secretion |
EXP |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
14 |
63,741,302 |
63,764,758 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
increases expression |
ISO |
1 |
133,534,891 |
133,572,084 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
affects expression |
ISO |
8 |
97,296,080 |
97,306,327 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
decreases expression |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
increases secretion |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases secretion |
ISO |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cyb5 |
cytochrome b-5 |
|
increases expression |
ISO |
18 |
85,020,806 |
85,049,255 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
ISO |
8 |
124,948,671 |
124,956,840 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
9,012,378 |
9,046,450 |
RGD:6480464 |
CTD |
| G |
Cyp2a12 |
cytochrome P450, family 2, subfamily a, polypeptide 12 |
|
increases expression |
ISO |
7 |
27,814,109 |
27,821,837 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
decreases expression |
ISO |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2c55 |
cytochrome P450, family 2, subfamily c, polypeptide 55 |
|
multiple interactions |
ISO |
19 |
39,081,509 |
39,117,177 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases response to substance |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects activity |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
|
multiple interactions |
EXP |
4 |
115,190,892 |
115,206,254 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
4 |
115,297,333 |
115,320,310 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
multiple interactions |
ISO |
5 |
4,080,674 |
4,104,697 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
4 |
6,192,759 |
6,202,778 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
3 |
17,971,950 |
18,143,338 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
increases expression |
ISO |
14 |
54,855,160 |
54,873,604 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino acid oxidase |
|
increases expression |
ISO |
5 |
114,453,835 |
114,475,469 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
increases expression |
ISO |
10 |
80,645,752 |
80,655,942 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
multiple interactions |
ISO |
X |
140,290,385 |
140,367,762 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
decreases expression |
ISO |
X |
140,290,385 |
140,367,762 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
10 |
126,727,849 |
126,733,344 |
RGD:6480464 |
CTD |
| G |
Ddn |
dendrin |
|
multiple interactions |
ISO |
15 |
98,634,213 |
98,638,356 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
EXP |
15 |
76,332,445 |
76,342,248 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
EXP |
7 |
106,302,173 |
106,331,223 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
multiple interactions |
ISO |
7 |
151,009,072 |
151,034,315 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases expression |
ISO |
4 |
106,964,070 |
106,979,748 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) |
|
increases expression |
ISO |
9 |
50,442,738 |
50,467,885 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
increases expression |
ISO |
11 |
69,832,107 |
69,859,034 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
multiple interactions |
ISO |
11 |
69,832,107 |
69,859,034 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
multiple interactions |
ISO |
7 |
138,175,590 |
138,265,142 |
RGD:6480464 |
CTD |
| G |
Dnm2 |
dynamin 2 |
|
decreases expression |
ISO |
9 |
21,229,389 |
21,311,568 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
decreases expression |
ISO |
17 |
46,633,738 |
46,636,567 |
RGD:6480464 |
CTD |
| G |
Drd1a |
dopamine receptor D1A |
|
decreases expression |
ISO |
13 |
54,146,552 |
54,151,027 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
9 |
49,148,767 |
49,215,319 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
9 |
49,148,767 |
49,215,319 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases expression |
ISO |
9 |
49,148,767 |
49,215,319 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
affects response to substance |
EXP |
16 |
43,762,355 |
43,822,952 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
|
multiple interactions |
ISO |
7 |
29,610,357 |
29,617,258 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
increases expression |
EXP |
4 |
119,834,029 |
119,839,965 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
ISO |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Eea1 |
early endosome antigen 1 |
|
decreases expression |
ISO |
10 |
95,403,297 |
95,508,152 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
9 |
78,326,260 |
78,329,531 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
|
multiple interactions |
ISO |
16 |
21,761,358 |
21,787,907 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases expression |
EXP |
3 |
58,329,743 |
58,361,423 |
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
decreases expression |
ISO |
5 |
31,489,931 |
31,495,512 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
8 |
28,370,799 |
28,386,128 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
8 |
28,370,799 |
28,386,128 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
increases expression |
ISO |
1 |
38,054,855 |
38,112,424 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
increases expression |
ISO |
1 |
38,054,855 |
38,112,424 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases expression |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, alpha non-neuron |
|
increases expression |
ISO |
4 |
149,611,306 |
149,622,982 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
affects expression |
ISO |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression |
ISO |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
ISO |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum (ER) to nucleus signalling 1 |
|
increases expression |
EXP |
11 |
106,258,934 |
106,349,110 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
4 |
150,229,200 |
150,242,989 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Ewsr1 |
Ewing sarcoma breakpoint region 1 |
|
increases expression |
EXP |
11 |
4,969,691 |
4,999,080 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
multiple interactions |
ISO |
3 |
122,598,310 |
122,602,424 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
ISO |
3 |
10,012,606 |
10,016,610 |
RGD:6480464 |
CTD |
| G |
Fabp6 |
fatty acid binding protein 6, ileal (gastrotropin) |
|
increases expression |
ISO |
11 |
43,409,614 |
43,415,013 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
ISO |
6 |
113,481,676 |
113,546,279 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
EXP |
6 |
113,481,676 |
113,546,279 |
RGD:6480464 |
CTD |
| G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
|
multiple interactions |
ISO |
1 |
172,981,300 |
172,989,534 |
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
|
increases expression |
ISO |
7 |
52,348,363 |
52,359,192 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthetase |
|
multiple interactions |
ISO |
3 |
88,897,510 |
88,905,867 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
ISO |
9 |
51,751,412 |
51,771,638 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
EXP |
19 |
45,811,288 |
45,817,374 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
multiple interactions |
ISO |
6 |
29,383,153 |
29,411,888 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
ISO |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
decreases expression |
ISO |
7 |
109,006,845 |
109,019,197 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
increases expression |
ISO |
7 |
109,006,845 |
109,019,197 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
increases expression |
ISO |
7 |
109,006,845 |
109,019,197 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
7 |
19,888,045 |
19,895,394 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
7 |
19,888,045 |
19,895,394 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
decreases expression |
ISO |
5 |
32,438,845 |
32,460,213 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
decreases expression |
ISO |
13 |
31,650,039 |
31,652,845 |
RGD:6480464 |
CTD |
| G |
Ftl1 |
ferritin light chain 1 |
|
increases expression |
ISO |
7 |
52,713,314 |
52,715,256 |
RGD:6480464 |
CTD |
| G |
Fut4 |
fucosyltransferase 4 |
|
increases expression |
ISO |
9 |
14,552,903 |
14,556,566 |
RGD:6480464 |
CTD |
| G |
Fut4 |
fucosyltransferase 4 |
|
multiple interactions |
ISO |
9 |
14,552,903 |
14,556,566 |
RGD:6480464 |
CTD |
| G |
Fyn |
Fyn proto-oncogene |
|
increases phosphorylation |
ISO |
10 |
39,089,605 |
39,285,187 |
RGD:6480464 |
CTD |
| G |
Fyn |
Fyn proto-oncogene |
|
multiple interactions |
ISO |
10 |
39,089,605 |
39,285,187 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic |
|
increases expression |
ISO |
11 |
101,229,044 |
101,239,217 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
multiple interactions |
EXP |
11 |
41,944,982 |
41,996,432 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
increases activity |
EXP |
11 |
41,944,982 |
41,996,432 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
affects response to substance |
EXP |
11 |
41,944,982 |
41,996,432 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
decreases expression |
ISO |
11 |
41,944,982 |
41,996,432 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
|
increases expression |
ISO |
5 |
71,352,296 |
71,487,088 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
|
decreases expression |
ISO |
5 |
71,352,296 |
71,487,088 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
|
multiple interactions |
ISO |
5 |
71,352,296 |
71,487,088 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
|
decreases expression |
ISO |
5 |
71,352,296 |
71,487,088 |
RGD:6480464 |
CTD |
| G |
Gabrb1 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 |
|
multiple interactions |
EXP |
5 |
72,091,255 |
72,528,483 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
|
affects response to substance |
EXP |
11 |
42,233,259 |
42,446,093 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
|
multiple interactions |
EXP |
11 |
41,723,697 |
41,814,180 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
|
affects response to substance |
ISO |
11 |
41,723,697 |
41,814,180 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
ISO |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gale |
galactose-4-epimerase, UDP |
|
increases expression |
ISO |
4 |
135,521,080 |
135,524,093 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
decreases expression |
ISO |
16 |
42,248,665 |
42,340,764 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
ISO |
16 |
42,248,665 |
42,340,764 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
increases expression |
ISO |
2 |
9,778,705 |
9,800,227 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
increases phosphorylation |
EXP |
14 |
63,817,752 |
63,864,097 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
multiple interactions |
EXP |
14 |
63,817,752 |
63,864,097 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
affects expression |
ISO |
11 |
102,748,650 |
102,758,514 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
|
decreases expression |
ISO |
19 |
58,311,182 |
58,528,956 |
RGD:6480464 |
CTD |
| G |
Ggcx |
gamma-glutamyl carboxylase |
|
decreases expression |
ISO |
6 |
72,364,327 |
72,380,701 |
RGD:6480464 |
CTD |
| G |
Gh |
growth hormone |
|
affects folding |
ISO |
11 |
106,161,582 |
106,163,124 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 subunit |
|
multiple interactions |
ISO |
11 |
55,328,315 |
55,421,292 |
RGD:6480464 |
CTD |
| G |
Glra2 |
glycine receptor, alpha 2 subunit |
|
decreases expression |
ISO |
X |
161,566,949 |
161,764,913 |
RGD:6480464 |
CTD |
| G |
Glra2 |
glycine receptor, alpha 2 subunit |
|
multiple interactions |
ISO |
X |
161,566,949 |
161,764,913 |
RGD:6480464 |
CTD |
| G |
Glra3 |
glycine receptor, alpha 3 subunit |
|
decreases expression |
ISO |
8 |
58,419,622 |
58,604,149 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta subunit |
|
increases expression |
ISO |
3 |
80,647,526 |
80,717,546 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase (glutamine synthetase) |
|
increases expression |
ISO |
1 |
155,747,075 |
155,756,844 |
RGD:6480464 |
CTD |
| G |
Gm2a |
GM2 ganglioside activator protein |
|
increases expression |
EXP |
11 |
54,911,619 |
54,924,400 |
RGD:6480464 |
CTD |
| G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
|
decreases expression |
ISO |
10 |
80,991,477 |
81,007,791 |
RGD:6480464 |
CTD |
| G |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
|
increases expression |
ISO |
5 |
141,235,898 |
141,306,385 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
increases expression |
ISO |
19 |
16,510,157 |
16,685,308 |
RGD:6480464 |
CTD |
| G |
Gna15 |
guanine nucleotide binding protein, alpha 15 |
|
increases expression |
ISO |
10 |
80,965,058 |
80,986,970 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
|
increases expression |
ISO |
5 |
17,770,953 |
17,866,231 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
increases expression |
ISO |
9 |
107,516,469 |
107,537,673 |
RGD:6480464 |
CTD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
increases expression |
ISO |
18 |
67,247,990 |
67,386,446 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
|
decreases expression |
ISO |
8 |
96,334,738 |
96,493,288 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
|
multiple interactions |
ISO |
8 |
96,334,738 |
96,493,288 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein, alpha q polypeptide |
|
increases expression |
ISO |
19 |
16,207,321 |
16,461,943 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein, alpha z subunit |
|
increases expression |
ISO |
10 |
74,429,976 |
74,478,622 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein, alpha z subunit |
|
multiple interactions |
ISO |
10 |
74,429,976 |
74,478,622 |
RGD:6480464 |
CTD |
| G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
|
increases expression |
ISO |
5 |
137,969,357 |
137,974,457 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
ISO |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
|
increases expression |
ISO |
3 |
32,482,450 |
32,515,457 |
RGD:6480464 |
CTD |
| G |
Gnb5 |
guanine nucleotide binding protein (G protein), beta 5 |
|
increases expression |
ISO |
9 |
75,159,202 |
75,193,478 |
RGD:6480464 |
CTD |
| G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
|
decreases expression |
ISO |
4 |
59,048,028 |
59,054,771 |
RGD:6480464 |
CTD |
| G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
|
multiple interactions |
ISO |
4 |
59,048,028 |
59,054,771 |
RGD:6480464 |
CTD |
| G |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
|
decreases expression |
ISO |
19 |
8,911,419 |
8,913,736 |
RGD:6480464 |
CTD |
| G |
Gng5 |
guanine nucleotide binding protein (G protein), gamma 5 |
|
decreases expression |
ISO |
3 |
146,162,800 |
146,168,507 |
RGD:6480464 |
CTD |
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
increases expression |
ISO |
10 |
80,411,369 |
80,477,670 |
RGD:6480464 |
CTD |
| G |
Gng8 |
guanine nucleotide binding protein (G protein), gamma 8 |
|
decreases expression |
ISO |
7 |
17,477,135 |
17,480,784 |
RGD:6480464 |
CTD |
| G |
Gnpat |
glyceronephosphate O-acyltransferase |
|
increases expression |
ISO |
8 |
127,386,933 |
127,413,957 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
increases expression |
ISO |
5 |
86,611,019 |
86,626,895 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamate oxaloacetate transaminase 1, soluble |
|
increases expression |
ISO |
19 |
43,574,242 |
43,599,095 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamate oxaloacetate transaminase 1, soluble |
|
multiple interactions |
ISO |
19 |
43,574,242 |
43,599,095 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
decreases expression |
EXP |
15 |
99,548,024 |
99,555,439 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol phosphate dehydrogenase 2, mitochondrial |
|
multiple interactions |
ISO |
2 |
57,090,089 |
57,223,130 |
RGD:6480464 |
CTD |
| G |
Gphn |
gephyrin |
|
increases expression |
ISO |
12 |
79,327,642 |
79,785,759 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
multiple interactions |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
EXP |
10 |
79,516,255 |
79,519,184 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
multiple interactions |
EXP |
10 |
79,516,255 |
79,519,184 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
multiple interactions |
ISO |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
decreases expression |
ISO |
11 |
56,825,193 |
57,143,746 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
affects expression |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
decreases expression |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
multiple interactions |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
|
increases expression |
ISO |
X |
38,754,481 |
39,031,778 |
RGD:6480464 |
CTD |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
|
decreases expression |
ISO |
9 |
4,417,893 |
4,796,234 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
increases expression |
ISO |
14 |
35,633,322 |
36,394,301 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
multiple interactions |
ISO |
14 |
35,633,322 |
36,394,301 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
decreases expression |
ISO |
6 |
63,206,851 |
64,616,273 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
multiple interactions |
ISO |
6 |
63,206,851 |
64,616,273 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
decreases expression |
ISO |
16 |
87,896,142 |
88,290,503 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
multiple interactions |
ISO |
16 |
87,896,142 |
88,290,503 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
|
increases expression |
ISO |
10 |
48,819,269 |
49,508,560 |
RGD:6480464 |
CTD |
| G |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
|
decreases expression |
ISO |
4 |
125,168,075 |
125,391,417 |
RGD:6480464 |
CTD |
| G |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
|
decreases expression |
ISO |
9 |
42,328,519 |
42,752,454 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
|
increases expression |
ISO |
7 |
25,794,868 |
25,857,388 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
increases expression |
ISO |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
increases expression |
ISO |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
decreases expression |
ISO |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
|
decreases expression |
ISO |
16 |
9,577,803 |
9,992,626 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
decreases expression |
ISO |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
multiple interactions |
ISO |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, NMDA2C (epsilon 3) |
|
decreases expression |
ISO |
11 |
115,110,483 |
115,128,557 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
|
decreases expression |
ISO |
7 |
53,087,853 |
53,122,051 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
|
multiple interactions |
ISO |
7 |
53,087,853 |
53,122,051 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
|
decreases expression |
ISO |
4 |
49,678,098 |
49,857,953 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, NMDA3B |
|
decreases expression |
ISO |
10 |
79,433,469 |
79,439,935 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
decreases expression |
ISO |
15 |
76,077,237 |
76,080,334 |
RGD:6480464 |
CTD |
| G |
Grip1 |
glutamate receptor interacting protein 1 |
|
affects expression |
ISO |
10 |
118,891,370 |
119,512,653 |
RGD:6480464 |
CTD |
| G |
Grip1 |
glutamate receptor interacting protein 1 |
|
decreases expression |
ISO |
10 |
118,891,370 |
119,512,653 |
RGD:6480464 |
CTD |
| G |
Grip2 |
glutamate receptor interacting protein 2 |
|
increases expression |
ISO |
6 |
91,711,503 |
91,757,387 |
RGD:6480464 |
CTD |
| G |
Gripap1 |
GRIP1 associated protein 1 |
|
multiple interactions |
ISO |
X |
7,367,121 |
7,397,689 |
RGD:6480464 |
CTD |
| G |
Gripap1 |
GRIP1 associated protein 1 |
|
increases expression |
ISO |
X |
7,367,121 |
7,397,689 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
decreases expression |
ISO |
10 |
10,408,551 |
10,802,129 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
decreases expression |
ISO |
5 |
9,485,236 |
9,725,352 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
multiple interactions |
ISO |
5 |
9,485,236 |
9,725,352 |
RGD:6480464 |
CTD |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
decreases expression |
ISO |
17 |
27,559,332 |
27,640,249 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
increases expression |
ISO |
7 |
94,732,678 |
95,283,573 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
multiple interactions |
ISO |
7 |
94,732,678 |
95,283,573 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
decreases expression |
ISO |
11 |
50,664,187 |
50,679,710 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
multiple interactions |
ISO |
11 |
50,664,187 |
50,679,710 |
RGD:6480464 |
CTD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
increases expression |
ISO |
6 |
110,595,592 |
111,517,224 |
RGD:6480464 |
CTD |
| G |
Grm8 |
glutamate receptor, metabotropic 8 |
|
decreases expression |
ISO |
6 |
27,225,121 |
28,084,369 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
multiple interactions |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
affects response to substance |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
increases expression |
ISO |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
affects response to substance |
ISO |
10 |
75,246,558 |
75,261,329 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
increases expression |
ISO |
10 |
75,236,867 |
75,244,159 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
increases expression |
ISO |
10 |
75,236,867 |
75,244,159 |
RGD:6480464 |
CTD |
| G |
Gtf2a2 |
general transcription factor II A, 2 |
|
increases expression |
ISO |
9 |
69,860,357 |
69,870,654 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G two S phase expressed protein 1 |
|
multiple interactions |
ISO |
15 |
85,690,137 |
85,707,003 |
RGD:6480464 |
CTD |
| G |
Gucy2g |
guanylate cyclase 2g |
|
multiple interactions |
ISO |
19 |
55,272,591 |
55,315,726 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
increases expression |
ISO |
5 |
130,464,891 |
130,478,698 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
multiple interactions |
EXP |
13 |
113,884,035 |
113,891,189 |
RGD:6480464 |
CTD |
| G |
Gzmb |
granzyme B |
|
multiple interactions |
EXP |
14 |
56,877,693 |
56,881,097 |
RGD:6480464 |
CTD |
| G |
H2-T10 |
histocompatibility 2, T region locus 10 |
|
multiple interactions |
ISO |
17 |
36,254,033 |
36,258,355 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
ISO |
10 |
92,951,513 |
92,979,488 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
ISO |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
ISO |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
EXP |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
EXP |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hao3 |
hydroxyacid oxidase (glycolate oxidase) 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
36,664,581 |
36,675,459 |
RGD:6480464 |
CTD |
| G |
Hgs |
HGF-regulated tyrosine kinase substrate |
|
decreases expression |
ISO |
11 |
120,328,949 |
120,345,298 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
ISO |
6 |
52,496,224 |
52,590,294 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
affects expression |
ISO |
12 |
75,008,854 |
75,048,517 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
ISO |
8 |
59,990,640 |
59,994,796 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
|
increases expression |
ISO |
3 |
98,084,354 |
98,114,661 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
ISO |
16 |
4,726,361 |
4,766,249 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatic nuclear factor 4, alpha |
|
decreases activity |
EXP |
2 |
163,372,924 |
163,398,643 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatic nuclear factor 4, alpha |
|
multiple interactions |
EXP |
2 |
163,372,924 |
163,398,643 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
decreases expression |
ISO |
15 |
103,070,863 |
103,075,386 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
increases expression |
EXP |
5 |
100,462,596 |
100,468,241 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
decreases expression |
ISO |
13 |
94,074,450 |
94,174,917 |
RGD:6480464 |
CTD |
| G |
Homer2 |
homer homolog 2 (Drosophila) |
|
decreases expression |
ISO |
7 |
88,745,367 |
88,851,811 |
RGD:6480464 |
CTD |
| G |
Hps1 |
Hermansky-Pudlak syndrome 1 homolog (human) |
|
affects expression |
EXP |
19 |
42,829,686 |
42,854,466 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
multiple interactions |
ISO |
10 |
127,427,992 |
127,444,564 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
multiple interactions |
EXP |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
affects response to substance |
EXP |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
EXP |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
increases expression |
ISO |
17 |
45,704,727 |
45,710,210 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
decreases expression |
ISO |
7 |
31,338,321 |
31,340,458 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A |
|
multiple interactions |
ISO |
9 |
48,707,318 |
48,719,204 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B |
|
multiple interactions |
ISO |
9 |
48,743,113 |
48,773,095 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase |
|
multiple interactions |
ISO |
13 |
8,884,852 |
8,891,642 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
affects expression |
ISO |
7 |
149,836,673 |
149,846,940 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
ISO |
1 |
72,871,078 |
72,899,048 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Ikzf4 |
IKAROS family zinc finger 4 |
|
decreases expression |
EXP |
10 |
128,069,471 |
128,083,049 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases secretion |
EXP |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
increases expression |
ISO |
7 |
4,724,657 |
4,729,743 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12a |
|
multiple interactions |
EXP |
3 |
68,494,566 |
68,502,469 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
affects secretion |
EXP |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
multiple interactions |
EXP |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects secretion |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha chain |
|
increases expression |
EXP |
2 |
11,564,419 |
11,614,821 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
multiple interactions |
ISO |
19 |
29,999,604 |
30,035,205 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects secretion |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6ra |
interleukin 6 receptor, alpha |
|
decreases expression |
ISO |
3 |
89,673,246 |
89,717,084 |
RGD:6480464 |
CTD |
| G |
Il6ra |
interleukin 6 receptor, alpha |
|
increases expression |
ISO |
3 |
89,673,246 |
89,717,084 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
increases expression |
ISO |
6 |
55,120,621 |
55,124,984 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
multiple interactions |
ISO |
5 |
28,397,952 |
28,405,202 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases phosphorylation |
EXP |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
decreases expression |
ISO |
7 |
87,856,469 |
87,948,217 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
affects phosphorylation |
EXP |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin alpha 1 |
|
decreases expression |
ISO |
13 |
115,748,287 |
115,892,172 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin alpha 2 |
|
increases response to substance |
ISO |
13 |
115,626,120 |
115,722,249 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin alpha 2 |
|
multiple interactions |
ISO |
13 |
115,626,120 |
115,722,249 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin alpha 5 (fibronectin receptor alpha) |
|
increases expression |
ISO |
15 |
103,174,717 |
103,197,179 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
|
multiple interactions |
ISO |
6 |
108,163,090 |
108,501,108 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
|
increases expression |
ISO |
6 |
108,163,090 |
108,501,108 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases phosphorylation |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
decreases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
|
multiple interactions |
ISO |
3 |
106,839,080 |
106,841,047 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
decreases expression |
ISO |
7 |
51,846,256 |
51,860,121 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
multiple interactions |
EXP |
2 |
55,289,567 |
55,447,936 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
multiple interactions |
ISO |
2 |
55,289,567 |
55,447,936 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
multiple interactions |
EXP |
16 |
94,970,290 |
95,219,303 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
increases activity |
EXP |
16 |
94,970,290 |
95,219,303 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
multiple interactions |
ISO |
16 |
94,970,290 |
95,219,303 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases activity |
EXP |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kdm3a |
lysine (K)-specific demethylase 3A |
|
decreases expression |
ISO |
6 |
71,538,966 |
71,582,899 |
RGD:6480464 |
CTD |
| G |
Kifc3 |
kinesin family member C3 |
|
multiple interactions |
ISO |
8 |
97,623,728 |
97,666,440 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
decreases expression |
EXP |
6 |
129,560,339 |
129,573,859 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
15 |
101,858,647 |
101,862,457 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
15 |
101,827,142 |
101,834,773 |
RGD:6480464 |
CTD |
| G |
L1cam |
L1 cell adhesion molecule |
|
multiple interactions |
ISO |
X |
71,099,119 |
71,126,173 |
RGD:6480464 |
CTD |
| G |
L1cam |
L1 cell adhesion molecule |
|
decreases activity |
ISO |
X |
71,099,119 |
71,126,173 |
RGD:6480464 |
CTD |
| G |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
|
multiple interactions |
ISO |
12 |
73,174,415 |
73,186,300 |
RGD:6480464 |
CTD |
| G |
Lactb2 |
lactamase, beta 2 |
|
multiple interactions |
ISO |
1 |
13,615,979 |
13,650,590 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
decreases expression |
ISO |
2 |
158,132,229 |
158,158,588 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
decreases expression |
ISO |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
7 |
54,101,174 |
54,110,997 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
ISO |
7 |
54,101,174 |
54,110,997 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
ISO |
9 |
21,528,038 |
21,554,363 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
4 |
101,390,012 |
101,487,959 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases response to substance |
ISO |
4 |
101,390,012 |
101,487,959 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
4 |
101,390,012 |
101,487,959 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
ISO |
4 |
101,390,012 |
101,487,959 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactose binding, soluble 9 |
|
increases expression |
ISO |
11 |
78,776,481 |
78,798,426 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lipa |
lysosomal acid lipase A |
|
multiple interactions |
ISO |
19 |
34,566,806 |
34,601,964 |
RGD:6480464 |
CTD |
| G |
Lman1 |
lectin, mannose-binding, 1 |
|
increases expression |
ISO |
18 |
66,140,393 |
66,162,289 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
multiple interactions |
ISO |
9 |
58,135,530 |
58,161,019 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
increases expression |
ISO |
14 |
70,009,283 |
70,095,641 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
increases expression |
ISO |
3 |
148,478,550 |
148,617,599 |
RGD:6480464 |
CTD |
| G |
Lyn |
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog |
|
decreases expression |
ISO |
4 |
3,605,268 |
3,718,759 |
RGD:6480464 |
CTD |
| G |
Lyn |
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog |
|
multiple interactions |
ISO |
4 |
3,605,268 |
3,718,759 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
affects expression |
ISO |
X |
16,196,824 |
16,264,938 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
1 |
66,221,903 |
66,489,157 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
affects expression |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
decreases expression |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
|
increases expression |
ISO |
10 |
80,568,692 |
80,587,442 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
|
increases expression |
ISO |
11 |
60,745,559 |
60,766,305 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
EXP |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases phosphorylation |
EXP |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
affects expression |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases expression |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
increases expression |
ISO |
15 |
88,961,014 |
88,971,133 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
affects expression |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases expression |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases expression |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
affects expression |
ISO |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
decreases expression |
ISO |
6 |
72,382,793 |
72,389,552 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
affects expression |
ISO |
18 |
82,644,515 |
82,755,029 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
multiple interactions |
ISO |
9 |
86,474,970 |
86,589,947 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
decreases expression |
ISO |
7 |
86,278,654 |
86,293,946 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
multiple interactions |
ISO |
5 |
34,976,296 |
34,979,763 |
RGD:6480464 |
CTD |
| G |
Mfsd12 |
major facilitator superfamily domain containing 12 |
|
multiple interactions |
ISO |
10 |
80,820,315 |
80,826,780 |
RGD:6480464 |
CTD |
| G |
Mgl2 |
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
|
decreases expression |
ISO |
11 |
69,943,859 |
69,951,044 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor |
|
increases expression |
ISO |
10 |
75,322,098 |
75,322,995 |
RGD:6480464 |
CTD |
| G |
Mip |
major intrinsic protein of eye lens fiber |
|
multiple interactions |
ISO |
10 |
127,662,894 |
127,668,867 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
decreases expression |
ISO |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
decreases expression |
EXP |
10 |
80,128,072 |
80,134,721 |
RGD:6480464 |
CTD |
| G |
Mlx |
MAX-like protein X |
|
increases expression |
ISO |
11 |
100,948,604 |
100,953,521 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
multiple interactions |
EXP |
5 |
135,582,783 |
135,613,792 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases activity |
EXP |
5 |
135,582,783 |
135,613,792 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases expression |
EXP |
5 |
135,582,783 |
135,613,792 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
decreases expression |
ISO |
9 |
7,272,514 |
7,283,333 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
8 |
95,351,227 |
95,377,319 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
8 |
95,351,227 |
95,377,319 |
RGD:6480464 |
CTD |
| G |
Mmp23 |
matrix metallopeptidase 23 |
|
decreases expression |
ISO |
4 |
155,024,764 |
155,027,493 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mnf1 |
mitochondrial nucleoid factor 1 |
|
multiple interactions |
ISO |
17 |
27,259,610 |
27,270,836 |
RGD:6480464 |
CTD |
| G |
Mpdz |
multiple PDZ domain protein |
|
multiple interactions |
ISO |
4 |
80,924,404 |
81,088,709 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
|
multiple interactions |
ISO |
11 |
97,177,030 |
97,191,234 |
RGD:6480464 |
CTD |
| G |
Mrps16 |
mitochondrial ribosomal protein S16 |
|
increases expression |
EXP |
14 |
21,210,453 |
21,212,777 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mtmr7 |
myotubularin related protein 7 |
|
multiple interactions |
ISO |
8 |
41,635,513 |
41,720,146 |
RGD:6480464 |
CTD |
| G |
Mtmr7 |
myotubularin related protein 7 |
|
multiple interactions |
ISO |
8 |
41,635,513 |
41,720,146 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Mtpn |
myotrophin |
|
increases expression |
ISO |
6 |
35,458,824 |
35,489,888 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
multiple interactions |
EXP |
3 |
137,752,819 |
137,806,352 |
RGD:6480464 |
CTD |
| G |
Mug1 |
murinoglobulin 1 |
|
increases expression |
ISO |
6 |
121,788,559 |
121,839,075 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
decreases expression |
ISO |
4 |
116,480,339 |
116,492,036 |
RGD:6480464 |
CTD |
| G |
Myl3 |
myosin, light polypeptide 3 |
|
decreases expression |
ISO |
9 |
110,666,185 |
110,672,298 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin, light polypeptide kinase |
|
increases activity |
ISO |
16 |
34,785,036 |
35,002,520 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin, light polypeptide kinase |
|
multiple interactions |
ISO |
16 |
34,785,036 |
35,002,520 |
RGD:6480464 |
CTD |
| G |
Myo1e |
myosin IE |
|
decreases expression |
ISO |
9 |
70,055,157 |
70,247,874 |
RGD:6480464 |
CTD |
| G |
Myo5b |
myosin VB |
|
multiple interactions |
ISO |
18 |
74,602,273 |
74,931,131 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
multiple interactions |
ISO |
1 |
88,241,294 |
88,256,030 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
multiple interactions |
ISO |
7 |
129,231,558 |
129,245,362 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
affects expression |
EXP |
14 |
68,701,941 |
68,705,802 |
RGD:6480464 |
CTD |
| G |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
|
decreases expression |
ISO |
14 |
56,443,632 |
56,452,780 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases expression |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X |
|
decreases expression |
ISO |
8 |
87,231,498 |
87,324,239 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
affects expression |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
|
multiple interactions |
ISO |
19 |
46,379,227 |
46,386,580 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
decreases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfyc |
nuclear transcription factor-Y gamma |
|
decreases expression |
ISO |
4 |
120,430,040 |
120,498,320 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide type A |
|
multiple interactions |
ISO |
4 |
147,374,855 |
147,376,176 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide type A |
|
increases expression |
ISO |
4 |
147,374,855 |
147,376,176 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
affects expression |
ISO |
15 |
79,616,781 |
79,635,139 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
increases expression |
ISO |
15 |
79,616,781 |
79,635,139 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
ISO |
6 |
49,772,728 |
49,779,506 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
ISO |
10 |
88,916,979 |
88,996,367 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
decreases expression |
ISO |
13 |
78,328,234 |
78,338,243 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
decreases expression |
ISO |
8 |
79,426,407 |
79,767,538 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
ISO |
8 |
79,426,407 |
79,767,538 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuron-glia-CAM-related cell adhesion molecule |
|
increases response to substance |
ISO |
12 |
45,429,872 |
45,702,833 |
RGD:6480464 |
CTD |
| G |
Nrg4 |
neuregulin 4 |
|
increases expression |
EXP |
9 |
55,068,029 |
55,131,432 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
decreases expression |
ISO |
8 |
130,882,973 |
131,029,376 |
RGD:6480464 |
CTD |
| G |
Nsfl1c |
NSFL1 (p97) cofactor (p47) |
|
decreases expression |
ISO |
2 |
151,320,044 |
151,337,041 |
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
increases expression |
ISO |
9 |
88,222,447 |
88,266,927 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases response to substance |
ISO |
10 |
101,944,390 |
101,953,052 |
RGD:6480464 |
CTD |
| G |
Nup98 |
nucleoporin 98 |
|
decreases expression |
ISO |
7 |
109,282,717 |
109,358,634 |
RGD:6480464 |
CTD |
| G |
Nxph3 |
neurexophilin 3 |
|
decreases expression |
EXP |
11 |
95,371,160 |
95,375,879 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
ISO |
7 |
139,749,158 |
139,768,081 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase, structural 1 |
|
increases expression |
ISO |
12 |
17,551,679 |
17,558,308 |
RGD:6480464 |
CTD |
| G |
Olfr78 |
olfactory receptor 78 |
|
decreases expression |
ISO |
7 |
109,889,235 |
109,907,985 |
RGD:6480464 |
CTD |
| G |
Oma1 |
OMA1 homolog, zinc metallopeptidase (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
102,986,451 |
103,039,033 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
decreases expression |
ISO |
1 |
5,578,574 |
5,592,947 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
ISO |
1 |
5,578,574 |
5,592,947 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases response to substance |
ISO |
10 |
3,308,332 |
3,557,940 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects response to substance |
EXP |
10 |
3,308,332 |
3,557,940 |
RGD:6480464 |
CTD |
| G |
Otx1 |
orthodenticle homolog 1 (Drosophila) |
|
decreases expression |
ISO |
11 |
21,894,767 |
21,901,654 |
RGD:6480464 |
CTD |
| G |
P2rx6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
|
decreases expression |
ISO |
16 |
17,561,978 |
17,572,105 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled 2 |
|
multiple interactions |
ISO |
7 |
108,145,086 |
108,160,505 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
decreases expression |
ISO |
15 |
83,206,037 |
83,295,036 |
RGD:6480464 |
CTD |
| G |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
|
increases expression |
ISO |
2 |
91,096,970 |
91,104,836 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
decreases expression |
ISO |
7 |
104,991,449 |
105,060,891 |
RGD:6480464 |
CTD |
| G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
|
decreases expression |
ISO |
1 |
99,717,671 |
99,992,209 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases cleavage |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases expression |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Pcbd1 |
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 |
|
increases expression |
ISO |
10 |
60,552,091 |
60,557,077 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
|
increases expression |
ISO |
2 |
172,978,574 |
172,984,755 |
RGD:6480464 |
CTD |
| G |
Pcm1 |
pericentriolar material 1 |
|
decreases expression |
ISO |
8 |
42,325,113 |
42,419,441 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
|
decreases expression |
ISO |
11 |
120,471,401 |
120,479,204 |
RGD:6480464 |
CTD |
| G |
Pdcl |
phosducin-like |
|
increases expression |
ISO |
2 |
37,205,594 |
37,214,852 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
increases expression |
ISO |
7 |
121,558,768 |
121,681,451 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP specific |
|
increases expression |
ISO |
9 |
20,970,158 |
21,017,692 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
affects response to substance |
ISO |
4 |
101,927,347 |
102,279,867 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
ISO |
4 |
101,927,347 |
102,279,867 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP specific |
|
decreases expression |
ISO |
13 |
109,444,371 |
110,741,682 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
|
increases expression |
ISO |
3 |
97,493,751 |
97,692,630 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
decreases expression |
ISO |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
multiple interactions |
ISO |
8 |
107,115,368 |
107,120,749 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
multiple interactions |
ISO |
2 |
129,513,737 |
129,515,604 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
decreases expression |
ISO |
2 |
129,513,737 |
129,515,604 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
affects response to substance |
ISO |
2 |
129,513,737 |
129,515,604 |
RGD:6480464 |
CTD |
| G |
Pdzd11 |
PDZ domain containing 11 |
|
multiple interactions |
ISO |
X |
97,818,245 |
97,821,246 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
multiple interactions |
ISO |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
affects expression |
EXP |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
decreases expression |
ISO |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
multiple interactions |
ISO |
7 |
86,882,150 |
86,887,911 |
RGD:6480464 |
CTD |
| G |
Pfdn5 |
prefoldin 5 |
|
decreases expression |
ISO |
15 |
102,156,547 |
102,161,921 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 |
|
increases expression |
ISO |
19 |
41,986,361 |
41,993,155 |
RGD:6480464 |
CTD |
| G |
Phgdh |
3-phosphoglycerate dehydrogenase |
|
decreases expression |
ISO |
3 |
98,117,094 |
98,143,892 |
RGD:6480464 |
CTD |
| G |
Phkg2 |
phosphorylase kinase, gamma 2 (testis) |
|
decreases expression |
ISO |
7 |
134,716,862 |
134,726,821 |
RGD:6480464 |
CTD |
| G |
Pi4kb |
phosphatidylinositol 4-kinase, catalytic, beta polypeptide |
|
decreases expression |
ISO |
3 |
94,778,653 |
94,810,765 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide |
|
increases expression |
ISO |
6 |
139,664,380 |
139,917,805 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
increases expression |
ISO |
3 |
32,335,073 |
32,367,408 |
RGD:6480464 |
CTD |
| G |
Pik3cb |
phosphatidylinositol 3-kinase, catalytic, beta polypeptide |
|
increases expression |
ISO |
9 |
98,938,821 |
99,040,630 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) |
|
affects expression |
ISO |
13 |
102,450,716 |
102,538,172 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) |
|
increases expression |
ISO |
13 |
102,450,716 |
102,538,172 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) |
|
multiple interactions |
ISO |
13 |
102,450,716 |
102,538,172 |
RGD:6480464 |
CTD |
| G |
Pik3r2 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) |
|
increases expression |
ISO |
8 |
73,292,080 |
73,300,611 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) |
|
decreases expression |
ISO |
4 |
115,894,519 |
115,975,661 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) |
|
multiple interactions |
ISO |
4 |
115,894,519 |
115,975,661 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase liver and red blood cell |
|
increases expression |
EXP |
3 |
88,940,064 |
88,950,516 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase liver and red blood cell |
|
multiple interactions |
EXP |
3 |
88,940,064 |
88,950,516 |
RGD:6480464 |
CTD |
| G |
Pla2g16 |
phospholipase A2, group XVI |
|
multiple interactions |
ISO |
19 |
7,631,949 |
7,663,035 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plcb3 |
phospholipase C, beta 3 |
|
increases expression |
ISO |
19 |
7,028,203 |
7,044,242 |
RGD:6480464 |
CTD |
| G |
Plcb4 |
phospholipase C, beta 4 |
|
increases expression |
ISO |
2 |
135,567,566 |
135,838,804 |
RGD:6480464 |
CTD |
| G |
Plcd1 |
phospholipase C, delta 1 |
|
increases expression |
ISO |
9 |
118,980,645 |
119,002,614 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
decreases expression |
ISO |
19 |
38,598,687 |
38,859,595 |
RGD:6480464 |
CTD |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
multiple interactions |
ISO |
2 |
160,557,046 |
160,601,496 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
increases expression |
ISO |
8 |
120,022,191 |
120,159,042 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
decreases expression |
ISO |
1 |
55,462,790 |
55,811,129 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
multiple interactions |
ISO |
1 |
55,462,790 |
55,811,129 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
multiple interactions |
ISO |
1 |
55,462,790 |
55,811,129 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
decreases expression |
ISO |
1 |
55,462,790 |
55,811,129 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
ISO |
9 |
92,437,061 |
92,503,266 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
ISO |
11 |
62,945,012 |
62,973,048 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
decreases expression |
ISO |
5 |
144,670,870 |
144,692,625 |
RGD:6480464 |
CTD |
| G |
Pnck |
pregnancy upregulated non-ubiquitously expressed CaM kinase |
|
multiple interactions |
ISO |
X |
70,901,333 |
70,905,167 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
4 |
33,332,398 |
33,335,762 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
decreases expression |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
multiple interactions |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
multiple interactions |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
multiple interactions |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
decreases secretion |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
increases expression |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
increases expression |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
|
decreases expression |
ISO |
1 |
167,805,603 |
167,932,765 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
decreases expression |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases activity |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases activity |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
increases expression |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppib |
peptidylprolyl isomerase B |
|
increases expression |
ISO |
9 |
65,907,976 |
65,914,436 |
RGD:6480464 |
CTD |
| G |
Ppp1r2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
|
decreases expression |
ISO |
16 |
31,251,627 |
31,275,363 |
RGD:6480464 |
CTD |
| G |
Ppp2r2a |
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform |
|
decreases expression |
ISO |
14 |
67,634,508 |
67,691,266 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
|
multiple interactions |
EXP |
3 |
136,333,734 |
136,598,743 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
|
increases expression |
EXP |
3 |
136,333,734 |
136,598,743 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
|
decreases expression |
ISO |
3 |
136,333,734 |
136,598,743 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
decreases expression |
ISO |
14 |
21,318,536 |
21,365,795 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
multiple interactions |
ISO |
14 |
21,318,536 |
21,365,795 |
RGD:6480464 |
CTD |
| G |
Ppp3cc |
protein phosphatase 3, catalytic subunit, gamma isoform |
|
decreases expression |
ISO |
14 |
70,617,705 |
70,689,256 |
RGD:6480464 |
CTD |
| G |
Ppp3cc |
protein phosphatase 3, catalytic subunit, gamma isoform |
|
multiple interactions |
ISO |
14 |
70,617,705 |
70,689,256 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
|
decreases expression |
ISO |
11 |
17,059,301 |
17,100,383 |
RGD:6480464 |
CTD |
| G |
Prf1 |
perforin 1 (pore forming protein) |
|
multiple interactions |
EXP |
10 |
60,760,584 |
60,767,011 |
RGD:6480464 |
CTD |
| G |
Rab1b |
RAB1B, member RAS oncogene family |
|
affects expression |
ISO |
19 |
5,099,207 |
5,106,996 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
ISO |
9 |
98,323,380 |
98,346,970 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Resp18 |
regulated endocrine-specific protein 18 |
|
multiple interactions |
ISO |
1 |
75,268,777 |
75,274,955 |
RGD:6480464 |
CTD |
| G |
Rev1 |
REV1 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
1 |
38,109,631 |
38,186,507 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin |
|
increases expression |
ISO |
X |
20,126,944 |
20,139,213 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog gene family, member A |
|
decreases expression |
ISO |
9 |
108,208,536 |
108,240,270 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
increases expression |
ISO |
14 |
51,710,752 |
51,725,826 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
multiple interactions |
ISO |
1 |
137,159,276 |
137,180,661 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
decreases expression |
ISO |
4 |
133,403,205 |
133,443,714 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
decreases expression |
ISO |
8 |
107,151,966 |
107,155,221 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
increases expression |
EXP |
17 |
34,168,797 |
34,175,344 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
increases expression |
EXP |
1 |
169,528,493 |
169,569,754 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium binding protein A4 |
|
increases expression |
ISO |
3 |
90,407,692 |
90,409,967 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
|
multiple interactions |
ISO |
3 |
90,472,993 |
90,473,956 |
RGD:6480464 |
CTD |
| G |
Sc4mol |
sterol-C4-methyl oxidase-like |
|
multiple interactions |
ISO |
8 |
67,196,942 |
67,212,375 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
ISO |
5 |
125,757,460 |
125,821,444 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
|
multiple interactions |
ISO |
19 |
44,368,166 |
44,381,354 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
decreases expression |
EXP |
9 |
75,491,173 |
75,531,863 |
RGD:6480464 |
CTD |
| G |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
|
multiple interactions |
ISO |
2 |
66,318,137 |
66,473,009 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2, liver |
|
multiple interactions |
ISO |
4 |
107,716,444 |
107,791,104 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
decreases expression |
ISO |
5 |
120,926,556 |
120,933,914 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
5 |
120,926,556 |
120,933,914 |
RGD:6480464 |
CTD |
| G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
|
increases expression |
ISO |
3 |
58,325,891 |
58,329,806 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
|
decreases expression |
ISO |
7 |
106,493,885 |
106,501,749 |
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
decreases expression |
EXP |
5 |
28,783,380 |
28,793,641 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
multiple interactions |
EXP |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
decreases activity |
EXP |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10, member 2 |
|
decreases expression |
ISO |
8 |
5,085,623 |
5,105,232 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
decreases expression |
ISO |
14 |
121,858,843 |
121,904,476 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
decreases expression |
ISO |
7 |
58,877,200 |
58,926,496 |
RGD:6480464 |
CTD |
| G |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
decreases expression |
ISO |
7 |
52,419,291 |
52,431,509 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases expression |
ISO |
10 |
76,496,004 |
76,513,171 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases expression |
ISO |
10 |
76,496,004 |
76,513,171 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
ISO |
2 |
102,498,840 |
102,630,941 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
ISO |
2 |
102,498,840 |
102,630,941 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
affects expression |
ISO |
15 |
8,584,124 |
8,660,807 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
ISO |
15 |
8,584,124 |
8,660,807 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
increases expression |
ISO |
11 |
20,202,183 |
20,232,716 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
multiple interactions |
ISO |
11 |
20,202,183 |
20,232,716 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
decreases expression |
ISO |
7 |
17,366,695 |
17,383,623 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
decreases expression |
ISO |
10 |
78,243,241 |
78,277,570 |
RGD:6480464 |
CTD |
| G |
Slc20a2 |
solute carrier family 20, member 2 |
|
increases expression |
ISO |
8 |
23,587,172 |
23,680,088 |
RGD:6480464 |
CTD |
| G |
Slc25a18 |
solute carrier family 25 (mitochondrial carrier), member 18 |
|
decreases expression |
ISO |
6 |
120,723,786 |
120,744,000 |
RGD:6480464 |
CTD |
| G |
Slc25a18 |
solute carrier family 25 (mitochondrial carrier), member 18 |
|
decreases expression |
ISO |
6 |
120,723,786 |
120,744,000 |
RGD:6480464 |
CTD |
| G |
Slc25a22 |
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
|
decreases expression |
ISO |
7 |
148,615,648 |
148,623,773 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
|
decreases expression |
ISO |
8 |
47,292,693 |
47,296,363 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
4 |
118,781,350 |
118,809,935 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
decreases expression |
ISO |
5 |
31,388,479 |
31,395,900 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
multiple interactions |
ISO |
5 |
31,388,479 |
31,395,900 |
RGD:6480464 |
CTD |
| G |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
|
increases expression |
ISO |
2 |
158,436,494 |
158,441,483 |
RGD:6480464 |
CTD |
| G |
Slc34a3 |
solute carrier family 34 (sodium phosphate), member 3 |
|
decreases expression |
ISO |
2 |
25,084,417 |
25,089,727 |
RGD:6480464 |
CTD |
| G |
Slc35b1 |
solute carrier family 35, member B1 |
|
increases expression |
ISO |
11 |
95,246,236 |
95,252,966 |
RGD:6480464 |
CTD |
| G |
Slc36a1 |
solute carrier family 36 (proton/amino acid symporter), member 1 |
|
decreases expression |
ISO |
11 |
55,017,842 |
55,049,832 |
RGD:6480464 |
CTD |
| G |
Slc38a5 |
solute carrier family 38, member 5 |
|
decreases expression |
ISO |
X |
7,848,518 |
7,857,305 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
3 |
90,052,114 |
90,057,534 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
EXP |
1 |
45,964,915 |
45,982,439 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
multiple interactions |
EXP |
1 |
45,964,915 |
45,982,439 |
RGD:6480464 |
CTD |
| G |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
|
increases expression |
ISO |
5 |
23,931,050 |
23,946,765 |
RGD:6480464 |
CTD |
| G |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
|
increases expression |
ISO |
7 |
57,165,669 |
57,214,863 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases expression |
ISO |
4 |
117,507,863 |
117,541,910 |
RGD:6480464 |
CTD |
| G |
Slc7a8 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 |
|
decreases expression |
ISO |
14 |
55,341,052 |
55,400,723 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Stk38 |
serine/threonine kinase 38 |
|
multiple interactions |
ISO |
17 |
29,107,830 |
29,144,882 |
RGD:6480464 |
CTD |
| G |
Svil |
supervillin |
|
multiple interactions |
ISO |
18 |
5,046,587 |
5,119,291 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated Nf-kappa B activator |
|
decreases expression |
ISO |
2 |
61,416,643 |
61,492,228 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
ISO |
8 |
112,514,336 |
112,523,704 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
increases expression |
ISO |
8 |
112,514,336 |
112,523,704 |
RGD:6480464 |
CTD |
| G |
Tbx19 |
T-box 19 |
|
affects response to substance |
ISO |
1 |
167,067,984 |
167,090,904 |
RGD:6480464 |
CTD |
| G |
Tbx5 |
T-box 5 |
|
decreases expression |
EXP |
5 |
120,284,672 |
120,335,227 |
RGD:6480464 |
CTD |
| G |
Tcp1 |
t-complex protein 1 |
|
multiple interactions |
ISO |
17 |
13,109,331 |
13,117,933 |
RGD:6480464 |
CTD |
| G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
decreases expression |
ISO |
3 |
81,762,334 |
81,779,650 |
RGD:6480464 |
CTD |
| G |
Tep1 |
telomerase associated protein 1 |
|
decreases expression |
ISO |
14 |
51,443,736 |
51,490,229 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
16 |
32,608,982 |
32,632,880 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
affects expression |
ISO |
16 |
32,608,982 |
32,632,880 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
EXP |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
EXP |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
ISO |
2 |
148,230,207 |
148,233,924 |
RGD:6480464 |
CTD |
| G |
Timm44 |
translocase of inner mitochondrial membrane 44 |
|
increases expression |
ISO |
8 |
4,259,731 |
4,275,905 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
multiple interactions |
EXP |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
increases expression |
ISO |
11 |
118,162,375 |
118,216,725 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
affects localization |
ISO |
7 |
72,441,051 |
72,516,130 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1 |
|
multiple interactions |
ISO |
11 |
117,676,833 |
117,687,328 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1 |
|
decreases activity |
ISO |
11 |
117,676,833 |
117,687,328 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
EXP |
4 |
66,488,845 |
66,503,831 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases response to substance |
EXP |
4 |
66,488,845 |
66,503,831 |
RGD:6480464 |
CTD |
| G |
Tmem171 |
transmembrane protein 171 |
|
multiple interactions |
ISO |
13 |
99,456,193 |
99,464,786 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
decreases expression |
ISO |
12 |
112,680,872 |
112,693,229 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
EXP |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Traf2 |
TNF receptor-associated factor 2 |
|
multiple interactions |
ISO |
2 |
25,373,502 |
25,402,414 |
RGD:6480464 |
CTD |
| G |
Traip |
TRAF-interacting protein |
|
multiple interactions |
ISO |
9 |
107,853,294 |
107,874,599 |
RGD:6480464 |
CTD |
| G |
Trip10 |
thyroid hormone receptor interactor 10 |
|
decreases expression |
ISO |
17 |
57,388,874 |
57,402,846 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions |
ISO |
5 |
115,072,163 |
115,108,430 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases response to substance |
ISO |
5 |
115,072,163 |
115,108,430 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
increases expression |
ISO |
15 |
98,780,278 |
98,783,932 |
RGD:6480464 |
CTD |
| G |
Tubb2b |
tubulin, beta 2B class IIB |
|
decreases expression |
ISO |
13 |
34,218,877 |
34,222,223 |
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
ISO |
17 |
35,970,865 |
35,975,246 |
RGD:6480464 |
CTD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
increases expression |
EXP |
10 |
94,977,796 |
95,008,292 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose dehydrogenase |
|
decreases expression |
ISO |
5 |
65,804,460 |
65,827,081 |
RGD:6480464 |
CTD |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
increases expression |
ISO |
1 |
90,062,587 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Usf1 |
upstream transcription factor 1 |
|
decreases expression |
ISO |
1 |
173,341,812 |
173,348,874 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
decreases expression |
ISO |
6 |
125,165,599 |
125,172,324 |
RGD:6480464 |
CTD |
| G |
Vamp2 |
vesicle-associated membrane protein 2 |
|
increases expression |
ISO |
11 |
68,902,030 |
68,905,883 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
decreases expression |
ISO |
4 |
150,421,414 |
150,432,062 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
increases expression |
ISO |
4 |
150,421,414 |
150,432,062 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Wfdc18 |
WAP four-disulfide core domain 18 |
|
increases expression |
EXP |
11 |
83,522,506 |
83,524,862 |
RGD:6480464 |
CTD |
Term paths to the root
|